FrancophonIA/ELRC3.0 huggingface dataset:
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Emtricitabine/Tenofovir disoproxil Mylan have also been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Emtricitabin/dizoproksiltenofovirat Mylan upoštevati zdravstveni delavci in bolniki, so vključeni tudi v povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo.
English: Emtricitabine/Tenofovir disoproxil Mylan is available as tablets (200 mg emtricitabine and 245 mg tenofovir disoproxil).
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Mylan je na voljo v obliki tablet (200 mg emtricitabina in 245 mg dizoproksiltenofovirata).
English: Emtricitabine/Tenofovir disoproxil Mylan is an HIV medicine that is used in combination with at least one other HIV medicine to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Slovenian: Emtricitabin/dizoproksiltenofovirat Mylan je zdravilo proti virusu HIV, ki se uporablja v kombinaciji z vsaj enim drugim tovrstnim zdravilom za zdravljenje odraslih, okuženih z virusom humane imunske pomanjkljivosti tipa 1 (HIV-1), tj. virusom, ki povzroča sindrom pridobljene imunske pomanjkljivosti (aids).
English: Emtricitabine/Tenofovir disoproxil Mylan does not cure HIV infection or AIDS, but it holds off damage to the immune system and the development of infections and diseases associated with AIDS.
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Mylan ne zdravi okužbe z virusom HIV ali aidsa, lahko pa upočasni slabšanje imunskega sistema ter razvoj okužb in bolezni, povezanih z aidsom.
English: What measures are being taken to ensure the safe and effective use of Emtricitabine/Tenofovir disoproxil Mylan?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Emtricitabin/dizoproksiltenofovirat Mylan?
English: An overview of Emtricitabine/Tenofovir disoproxil Mylan and why it is authorised in the EU
Slovenian: Pregled zdravila Emtricitabin/dizoproksiltenofovirat Mylan in zakaj je odobreno v EU
English: Emtricitabine/Tenofovir disoproxil Mylan is also used to help prevent sexually transmitted HIV-1 infection in adults and adolescents who are at high risk of being infected (pre-exposure prophylaxis or PrEP).
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Mylan se uporablja tudi kot pomoč pri preprečevanju spolno prenosljive okužbe z virusom HIV-1 pri odraslih in mladostnikih, pri katerih je tveganje za okužbo veliko (predekspozicijska profilaksa oziroma PrEP).
English: For the treatment of HIV-infection, Emtricitabine/Tenofovir disoproxil Mylan, taken in combination with at least one other HIV medicine, reduces the amount of HIV in the blood and keeps it at a low level.
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Mylan v kombinaciji z vsaj enim drugim zdravilom proti okužbi z virusom HIV znižuje količino virusa HIV v krvi in jo zadržuje na nizki ravni.
English: As for every medicine, the company provided studies on the quality of Emtricitabine/Tenofovir disoproxil Mylan.
Slovenian: Tako kot za vsako zdravilo, je podjetje predložilo študije o kakovosti zdravila Emtricitabin/dizoproksiltenofovirat Mylan.
English: For more information about using Emtricitabine/Tenofovir disoproxil Mylan, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Emtricitabin/dizoproksiltenofovirat Mylan glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: As for all medicines, data on the use of Emtricitabine/Tenofovir disoproxil Mylan are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Emtricitabin/dizoproksiltenofovirat Mylan stalno spremljajo.
English: Both emtricitabine and tenofovir work in similar ways by blocking the activity of reverse transcriptase, an enzyme produced by HIV that allows it to reproduce itself in the cells it has infected.
Slovenian: Emtricitabin in tenofovir na podoben način zavirata dejavnost reverzne transkriptaze, tj. encima, ki ga tvori virus HIV in ki mu omogoča, da se lahko razmnožuje v celicah, ki jih je virus okužil.
English: Emtricitabine/Tenofovir disoproxil Mylan (emtricitabine / tenofovir disoproxil)
Slovenian: Emtricitabin/dizoproksiltenofovirat Mylan (emtricitabin/dizoproksiltenofovirat)
English: Emtricitabine/Tenofovir disoproxil Mylan can only be obtained with a prescription and treatment should be started by a doctor who has experience in the management of HIV infection.
Slovenian: Predpisovanje in izdaja zdravila Emtricitabin/dizoproksiltenofovirat Mylan je le na recept, zdravljenje z njim pa mora uvesti zdravnik, ki ima izkušnje z zdravljenjem okužbe z virusom HIV.
English: For pre-exposure prophylaxis of HIV-1 infection, it is expected that Emtricitabine/Tenofovir disoproxil Mylan in the blood will stop the virus from multiplying and spreading from the site of infection in case the individual is exposed to the virus.
Slovenian: Pri predekspozicijski profilaksi pred okužbo z virusom HIV-1 naj bi zdravilo Emtricitabin/dizoproksiltenofovirat Mylan v krvi po pričakovanjih v primeru izpostavljenosti posameznika virusu preprečilo razmnoževanje in širjenje virusa z mesta okužbe.
English: Other information about Emtricitabine/Tenofovir disoproxil Mylan
Slovenian: Druge informacije o zdravilu Emtricitabin/dizoproksiltenofovirat Mylan
English: The company that markets Emtricitabine/Tenofovir disoproxil Mylan will provide an information pack to doctors which covers the potential harmful effects of Emtricitabine/Tenofovir disoproxil Mylan on kidney function and information about use for pre-exposure prophylaxis.
Slovenian: Podjetje, ki trži zdravilo Emtricitabin/dizoproksiltenofovirat Mylan, bo pripravilo informacijsko gradivo za zdravnike, ki bo obsegalo opis možnih škodljivih učinkov tega zdravila na delovanje ledvic in informacije o njegovi uporabi za predekspozijsko profilakso.
English: What are the benefits and risks of Emtricitabine/Tenofovir disoproxil Mylan?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Emtricitabin/dizoproksiltenofovirat Mylan?
English: Emtricitabine/Tenofovir disoproxil Mylan contains two active substances: emtricitabine, which is a nucleoside reverse transcriptase inhibitor; and tenofovir disoproxil, which is a ‘prodrug' of tenofovir.
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Mylan vsebuje dve učinkovini: emtricitabin, ki je nukleozidni zaviralec reverzne transkriptaze, in dizoproksiltenofovirat, ki je „predzdravilo“ tenofovirja.
English: What is Emtricitabine/Tenofovir disoproxil Mylan and what is it used for?
Slovenian: Kaj je zdravilo Emtricitabin/dizoproksiltenofovirat Mylan in za kaj se uporablja?
English: Why is Emtricitabine/Tenofovir disoproxil Mylan authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Emtricitabin/dizoproksiltenofovirat Mylan odobreno v EU?
English: Therefore, the Agency's view was that, as for Truvada, the benefit of Emtricitabine/Tenofovir disoproxil Mylan outweighs the identified risk and it can be authorised for use in the EU.
Slovenian: Zato je menila, da koristi zdravila Emtricitabin/dizoproksiltenofovirat Mylan, enako kot pri zdravilu Truvada, odtehtajo znana tveganja in se zdravilo lahko odobri v EU.
English: Emtricitabine/Tenofovir disoproxil Mylan contains two active substances, emtricitabine and tenofovir disoproxil.
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Mylan vsebuje dve učinkovini, emtricitabin in dizoproksiltenofovirat.
English: How is Emtricitabine/Tenofovir disoproxil Mylan used?
Slovenian: Kako se zdravilo Emtricitabin/dizoproksiltenofovirat Mylan uporablja?
English: How has Emtricitabine/Tenofovir disoproxil Mylan been studied?
Slovenian: Kako je bilo zdravilo Emtricitabin/dizoproksiltenofovirat Mylan raziskano?
English: How does Emtricitabine/Tenofovir disoproxil Mylan work?
Slovenian: Kako zdravilo Emtricitabin/dizoproksiltenofovirat Mylan deluje?
English: Date of first authorisation: 15 July 1998 Date of latest renewal: 15 July 2008
Slovenian: Datum pridobitve dovoljenja za promet: 15. julij 1998 Datum zadnjega podaljšanja dovoljenja za promet: 15. julij 2008
English: Some other medicines may influence the use of Iscover or vice versa.
Slovenian: Nekatera druga zdravila lahko vplivajo na uporabo zdravila Iscover in obratno.
English: 67019 Scoppito (AQ) - Italy
Slovenian: 67019 Scoppito (AQ) - Italija
English: You should take Iscover for as long as your doctor continues to prescribe it.
Slovenian: Zdravilo Iscover morate jemati, vse dokler vam ga vaš zdravnik predpisuje.
English: Strada Statale 17, Km 22 67019 Scoppito (AQ) - Italy
Slovenian: Strada Statale 17, Km 22 67019 Scoppito (AQ) - Italija
English: You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Iscover and acetylsalicylic acid for this condition.
Slovenian: Povedati so vam morali, da so "peroralni antikoagulanti" pri tej motnji učinkovitejši kot acetilsalicilna kislina ali kombinirana uporaba zdravila Iscover in acetilsalicilne kisline.
English: The most common side effect reported with Iscover is bleeding.
Slovenian: Najpogostejši neželeni učinek , o katerem so poročali z zdravilom Iscover je krvavitev.
English: What Iscover is and what it is used for
Slovenian: KAJ JE ZDRAVILO ISCOVER IN ZA KAJ GA UPORABLJAMO
English: • Hypersensitivity to the active substance or to any of the excipients listed in section 2 or section
Slovenian: • Preobčutljivost za zdravilno učinkovino ali katerokoli pomožno snov, navedeno v poglavju 2 ali v poglavju 6.1.
English: If you forget to take Iscover
Slovenian: Če ste pozabili vzeti zdravilo Iscover
English: Other medicines and Iscover
Slovenian: Druga zdravila in zdravilo Iscover
English: In CURE, there was no excess in major bleeds with clopidogrel plus ASA within 7 days after coronary bypass graft surgery in patients who stopped therapy more than five days prior to surgery.
Slovenian: V CURE število velikih krvavitev s klopidogrelom in ASA ni bilo prekoračeno v 7 dneh po koronarni premostitveni operaciji pri bolnikih, ki so prenehali z zdravljenjem več kot 5 dni pred kirurškim posegom.
English: If you stop taking Iscover Do not stop the treatment unless your doctor tells you so.
Slovenian: Ne prekinite zdravljenja razen , če tako odloči zdravnik.
English: Your doctor should have prescribed Iscover plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding.
Slovenian: Zdravnik naj bi vam predpisal zdravilo Iscover skupaj z acetilsalicilno kislino, če ne morete prejemati "peroralnih antikoagulantov", ali če nimate tveganja za večjo krvavitev.
English: Data from the CAPRIE study indicate that phenytoin and tolbutamide which are metabolised by CYP2C9 can be safely co-administered with clopidogrel.
Slovenian: Podatki študije CAPRIE kažejo, da se lahko fenitoin in tolbutamid, ki se presnavljata s CYP2C9 sočasno s klopidogrelom varno uporabljata.
English: If you become pregnant while taking Iscover, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.
Slovenian: Če med zdravljenjem z zdravilom Iscover zanosite, se takoj posvetujte s svojim zdravnikom, saj jemanje klopidogrela med nosečnostjo ni priporočljivo.
English: • Paediatric population Clopidogrel should not be used in children because of efficacy concerns (see section 5.1).
Slovenian: • Pediatrična populacija Klopidogrel naj se pri otrocih ne uporablja iz razlogov, ki zadevajo učinkovitost (glejte poglavje
English: If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Iscover in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever.
Slovenian: Če ste doživeli hudo bolečino v prsih (nestabilna angina pektoris ali srčni napad), so vam morda predpisali zdravilo Iscover v kombinaciji z acetilsalicilno kislino, učinkovino, ki je prisotna v številnih zdravilih, ki se uporabljajo za lajšanje bolečine in zniževanje zvišane telesne temperature.
English: Then, the recommended dose is one 75-mg tablet of Iscover per day as described above.
Slovenian: Nato je priporočeni odmerek ena 75-mg tableta zdravila Iscover na dan, kot je opisano zgoraj.
English: If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Iscover.
Slovenian: Če ste noseči ali mislite, da ste noseči, morate o tem obvestiti svojega zdravnika ali farmacevta, preden vzamete zdravilo Iscover.
English: What Iscover is and what it is used for What you need to know before you take Iscover How to take Iscover
Slovenian: Kaj je zdravilo Iscover in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Iscover Kako jemati zdravilo Iscover Možni neželeni učinki
English: While you are taking Iscover:
Slovenian: Ko jemljete zdravilo Iscover:
English: You have been prescribed Iscover to help prevent blood clots and reduce the risk of these severe events because: - You have a condition of hardening of arteries (also known as atherosclerosis), and - You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease, or - You have experienced a severe type of chest pain known as ‘unstable angina' or ‘myocardial infarction' (heart attack).
Slovenian: Zdravilo Iscover vam je predpisan za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate stanje otrdelih arterij (znano tudi kot ateroskleroza), in - ste predhodno doživeli srčni napad, kap ali imeli stanje, ki je znano kot periferna arterijska bolezen, ali - ste doživeli hudo obliko bolečine v prsih, znano kot “nestabilna angina” ali “miokardni infarkt” (srčni napad).
English: If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Iscover.
Slovenian: Če menite, da se karkoli od navedenega nanaša na vas, ali če ste kakorkoli v dvomih, se posvetujte s svojim zdravnikom, preden boste vzeli zdravilo Iscover.
English: The recommended dose, including for patients with a condition called ‘atrial fibrillation' (an irregular heartbeat), is one 75 mg tablet of Iscover per day to be taken orally with or without food, and at the same time each day.
Slovenian: Priporočeni odmerek, vključno za bolnike, ki imajo bolezensko stanje, imenovano "atrijska fibrilacija" (nepravilen srčni utrip), je ena 75 mg tableta zdravila Plavix na dan, ki jo lahko vzamete s hrano ali brez nje; odmerek morate jemati vsak dan ob istem času.
English: If you forget to take a dose of Iscover, but remember within 12 hours of your usual time, take your tablet straightaway and then take your next tablet at the usual time.
Slovenian: Če pozabite vzeti odmerek zdravila Iscover in se nanj spomnite do 12 ur po ustaljenem času, takoj vzemite tableto in nato vzemite naslednjo tableto spet ob ustaljenem času jemanja.
English: Iscover 75 mg film-coated tablets Clopidogrel should be given as a single daily dose of 75 mg.
Slovenian: Iscover 75 mg filmsko obložene tablete Klopidogrel se mora dajati kot enkratni dnevni odmerek 75 mg.
English: Iscover 300 mg film-coated tablets This 300 mg tablet of clopidogrel is intended for use as a loading dose.
Slovenian: Iscover 300 mg filmsko obložene tablete Ta 300 mg tableta klopidogrela je namenjena za uporabo kot udarni odmerek.
English: Iscover is taken by adults to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).
Slovenian: Zdravilo Iscover jemljejo odrasli za preprečevanje nastanka krvnih strdkov (trombov) v otrdelih krvnih žilah (arterijah), proces je znan kot aterotromboza in lahko vodi do aterotrombotičnih dogodkov (kot so kap, srčni napad ali smrt).
English: For the 7, 14, 28 and 84 tablets pack sizes, you can check the day on which you last took a tablet of Iscover by referring to the calendar printed on the blister.
Slovenian: Na koledarčku, ki je natisnjen na pretisnem omotu pri pakiranjih po 7, 14, 28 in 84 tablet, lahko preverite, kateri dan ste zadnjič vzeli tableto Iscoverzdravila Iscover.
English: Iscover is supplied in cardboard cartons containing: 7, 14, 28, 30, 84, 90 and 100 tablets in PVC/PVDC/Aluminium blisters or in all aluminium blisters 50x1 tablets in PVC/PVDC/Aluminium blisters or in all aluminium perforated unit-dose blisters.
Slovenian: Zdravilo Iscover je na voljo v škatlah, ki vsebujejo: - 7, 14, 28, 30, 84, 90 in 100 tablet v PVC/PVDC/alu pretisnih omotih ali v pretisnih omotih iz aluminija, - 50x1 tableta v PVC/PVDC aluminijastih pretisnih omotih ali v aluminijastih perforiranih pretisnih omotih za enkratni odmerek.
English: 5 How to store Iscover Contents of the pack and other information
Slovenian: Shranjevanje zdravila Iscover Vsebina pakiranja in dodatne informacije
English: Iscover contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products.
Slovenian: Zdravilo Iscover vsebuje klopidogrel in spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
English: As a precautionary measure, breast-feeding should not be continued during treatment with Iscover.
Slovenian: Iz varnostnih razlogov naj se z dojenjem med zdravljenjem z zdravilom Iscover ne nadaljuje.
English: How to take Iscover
Slovenian: Kako jemati zdravilo Iscover
English: Marketing Authorisation Holder: sanofi-aventis groupe 54, rue La Boétie F-75008 Paris
Slovenian: Imetnik dovoljenja za promet: sanofi-aventis groupe 54, rue La Boétie F-75008 Paris
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu/
Slovenian: DATUM ZADNJE REVIZIJE BESEDILA Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu/.
English: The dose of 0.2 mg/kg achieved the mean percent inhibition of 49.3% (5 µM ADP-induced platelet aggregation) which was comparable to that of adults taking Iscover 75 mg/day.
Slovenian: Odmerek 0,2 mg/kg je dosegel povprečno 49,3 % zavrtje (agregacija trombocitov povzročena s 5 µM ADP), primerljivo kot pri odraslih ob uporabi zdravila Plavix v odmerku 75 mg/dan.
English: What you need to know before you take Iscover Do not take Iscover
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Iscover
English: Iscover is unlikely to affect your ability to drive or to use machines.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Iscover vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
English: NSAIDs: in a clinical study conducted in healthy volunteers, the concomitant administration of clopidogrel and naproxen increased occult gastrointestinal blood loss.
Slovenian: NSAIDs; “Non-Steroidal Anti-Inflammatory Drugs”: v klinični študiji, izvedeni pri zdravih prostovoljcih, je sočasna uporaba klopidogrela in naproksena povečala okultno izgubo krvi iz prebavil.
English: What Iscover looks like and contents of the pack
Slovenian: Izgled zdravila Iscover in vsebina pakiranja
English: Iscover may be taken with or without food.
Slovenian: Zdravilo Iscover skupaj s hrano in pijačo Zdravilo Iscover lahko jemljete s hrano ali brez nje.
English: If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Iscover (1 tablet of 300 mg or 4 tablets of 75 mg) once at the start of treatment.
Slovenian: Če ste imeli hudo bolečino v prsih (nestabilna angina ali srčna kap), vam lahko zdravnik na začetku zdravljenja da enkrat 300 mg zdravila Iscover (eno 300-mg tableto ali štiri 75-mg tablete).
English: If any of the situations mentioned below apply to you, you should tell your doctor before taking Iscover:
Slovenian: Opozorila in previdnostni ukrepi Če katerokoli od spodaj navedenih stanj velja za vas, morate o tem obvestiti svojega zdravnika, preden boste vzeli zdravilo Iscover:
English: Contact your doctor or the nearest hospital emergency department because of the increased risk of bleeding.
Slovenian: Če ste vzeli večji odmerek zdravila Iscover, kot bi smeli Zaradi povečanega tveganja krvavitve se posvetujte s svojim zdravnikom ali oddelkom najbližje bolnišnične nujne zdravniške pomoči.
English: Iscover 75-mg film-coated tablets are round, biconvex, pink, engraved on one side with the number ‘75' and on the other side with the number ‘1171'.
Slovenian: Zdravilo Iscover 75 mg filmsko obložene tablete so okrogle, bikonveksne , rožnate barve, z vtisnjeno številko “75” na eni strani in številko “1171” na drugi strani.
English: Iscover contains lactose
Slovenian: Zdravilo Iscover vsebuje laktozo
English: Iscover contains lactose.
Slovenian: Zdravilo Iscover vsebuje laktozo.
English: Pink, round, biconvex, engraved with «75» on one side and «1171» on the other side.
Slovenian: Rožnate, okrogle, bikonveksne filmsko obložene tablete, z vtisnjeno številko "75" na eni strani in "1171" na drugi strani.
English: (listed in section 6).
Slovenian: Glejte poglavje 4).
English: Iscover is supplied in cardboard cartons containing 4x1, 10x1, 30x1 and 100x1 tablets in all aluminium perforated unit-dose blisters.
Slovenian: Zdravilo Iscover je na voljo v škatlah, ki vsebujejo 4x1, 10x1, 30x1, in 100x1 tableto v perforiranih pretisnih omotih za enkratni odmerek, ki so v celoti iz aluminija.
English: If you cut or injure yourself, it may take longer than usual for bleeding to stop.
Slovenian: Če doživite podaljšanje krvavitve v času jemanja zdravila Iscover Če se urežete ali poškodujete, lahko traja dlje kot običajno, da se vam krvavitev ustavi.
English: Thrombotic thrombocytopenic purpura (TTP) (see section 4.4), aplastic anaemia, pancytopenia, agranulocytosis, severe thrombocytopenia, acquired haemophilia A, granulocytopenia, anaemia
Slovenian: Trombotična trombocitopenična purpura (TTP) (glejte poglavje 4.4), aplastična anemija, pancitopenija, agranulocitoza, huda trombocitopenija, pridobljena hemofilija
English: Iscover 300-mg film-coated tablets are oblong, pink, engraved on one side with the number ‘300' and on the other side with the number ‘1332'.
Slovenian: Zdravilo Iscover 300 mg filmsko obložene tablete so podolgovate, rožnate tablete, , z vtisnjeno številko “300” na eni strani in številko “1332” na drugi strani.
English: If Iscover is supplied in PVC/PVDC/aluminium blisters, store below 30°C.
Slovenian: Zdravilo Iscover, ki je na voljo v PVC/PVDC/alu pretisnih omotih shranjujte pri temperaturi do 30C.
English: Pink, oblong, engraved with «300» on one side and «1332» on the other side.
Slovenian: Rožnate, podolgovate filmsko obložene tablete z vtisnjeno številko "300" na eni strani in "1332" na drugi strani.